MangoRx
Reviewed by Iacob Pastina, Independent Researcher
Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
MangoRx scores 7.5/10 in our independent review, starting at $299/mo for compounded GLP-1 medications. MangoRx exclusively offers oral dissolving tablets — no injections whatsoever. Being publicly traded (NASDAQ: MGRX) provides SEC-level transparency that private competitors can't match.
Quick Facts
What We Like
- +Oral dissolving tablets exclusively — zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
- +Free 100% online consultation with no video call required
What Could Be Better
- −$299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
- −Early-stage public company with limited revenue — stock performance reflects financial uncertainty
- −Only oral tablet format available — no injectable options if you want higher bioavailability
✓Best For
- •Needle-phobic patients who want oral-only GLP-1 from a publicly traded company with regulatory transparency.
✗Not Ideal For
- •Budget-conscious patients — $299/mo for oral semaglutide is 2-3x the cost of injectable alternatives.
How MangoRx Works
Free Online Consultation
Complete a 100% online consultation with a licensed medical professional — no video call required.
Physician Reviews Within 1-2 Days
A physician reviews your chart, questionnaire, and medical history within 1-2 business days.
Monthly Supply Ships Discreetly
If approved, your monthly supply of oral dissolving tablets ships discreetly to your door.
Medications Available
Pricing Details
Slim (Oral Semaglutide + B6)
$299/moMonthly oral dissolving semaglutide tablet with Vitamin B6 for nausea reduction
Trim (Oral Tirzepatide)
$399/moMonthly oral dissolving tirzepatide tablet
Cancellation policy: Not publicly disclosed
Ready to get started?
Visit MangoRxOur Verdict
MangoRx fills a specific niche: oral-only GLP-1 with public-company accountability. The NASDAQ listing is a genuine trust signal. But at $299-399/mo for compounded oral tablets, it's expensive compared to $99-179/mo injectable alternatives. The company is early-stage with limited revenue. Best for patients with a strong needle phobia who value corporate transparency; overpriced for everyone else.
Key differentiator: Oral dissolving tablets exclusively (zero injections) from a publicly traded company (NASDAQ: MGRX) with SEC-level financial transparency.
Frequently Asked Questions
Are MangoRx medications injections?+
Why is MangoRx more expensive?+
Is MangoRx publicly traded?+
Alternatives to MangoRx
Similar providers by type, price, and features
Helpful Tools
MangoRx
From $299/mo